Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers.

Archer M, Kampman O, Bloigu A, Bloigu R, Luoto K, Kultti J, Hämäläinen M, Moilanen E, Leinonen E, Niemelä O.

Alcohol Alcohol. 2019 May 1;54(3):243-250. doi: 10.1093/alcalc/agz002.

PMID:
30809628
2.

Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder.

Archer M, Niemelä O, Luoto K, Kultti J, Hämäläinen M, Moilanen E, Koivukangas A, Leinonen E, Kampman O.

Alcohol. 2019 Dec;81:21-26. doi: 10.1016/j.alcohol.2019.02.001. Epub 2019 Feb 12.

PMID:
30769022
3.

Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial.

Luoto KE, Lindholm LH, Paavonen V, Koivukangas A, Lassila A, Leinonen E, Kampman O.

BMC Psychiatry. 2018 Jul 27;18(1):238. doi: 10.1186/s12888-018-1820-x.

4.

Temperament clusters associate with anxiety disorder comorbidity in depression.

Paavonen V, Luoto K, Lassila A, Leinonen E, Kampman O.

J Affect Disord. 2018 Aug 15;236:252-258. doi: 10.1016/j.jad.2018.04.084. Epub 2018 Apr 23.

PMID:
29751240
5.

Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking.

Paavonen V, Luoto K, Lassila A, Leinonen E, Kampman O.

Compr Psychiatry. 2018 Jul;84:26-31. doi: 10.1016/j.comppsych.2018.04.001. Epub 2018 Apr 7.

PMID:
29677572
6.

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse.

Paavonen V, Luoto K, Koivukangas A, Lassila A, Leinonen E, Kampman O.

Psychiatry Res. 2016 Nov 30;245:250-258. doi: 10.1016/j.psychres.2016.08.043. Epub 2016 Aug 16.

PMID:
27565696
7.

Outcome of patients with dual diagnosis in secondary psychiatric care.

Luoto KE, Koivukangas A, Lassila A, Kampman O.

Nord J Psychiatry. 2016 Aug;70(6):470-6. doi: 10.3109/08039488.2016.1160149. Epub 2016 Apr 6.

PMID:
27049473
8.

Phenotypic rescue of a Drosophila model of mitochondrial ANT1 disease.

Vartiainen S, Chen S, George J, Tuomela T, Luoto KR, O'Dell KM, Jacobs HT.

Dis Model Mech. 2014 Jun;7(6):635-48. doi: 10.1242/dmm.016527. Epub 2014 May 8.

9.

Education of research ethics for clinical investigators with Moodle tool.

Halkoaho A, Matveinen M, Leinonen V, Luoto K, Keränen T.

BMC Med Ethics. 2013 Dec 12;14:53. doi: 10.1186/1472-6939-14-53.

10.

[Assessment of an addiction psychiatric patient within primary health care].

Lindholm L, Luoto K, Koivukangas A, Kampman O.

Duodecim. 2013;129(19):2057-62. Review. Finnish.

PMID:
24218734
11.

Tumor hypoxia as a driving force in genetic instability.

Luoto KR, Kumareswaran R, Bristow RG.

Genome Integr. 2013 Oct 24;4(1):5. doi: 10.1186/2041-9414-4-5.

12.

PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

Fraser M, Zhao H, Luoto KR, Lundin C, Coackley C, Chan N, Joshua AM, Bismar TA, Evans A, Helleday T, Bristow RG.

Clin Cancer Res. 2012 Feb 15;18(4):1015-27. doi: 10.1158/1078-0432.CCR-11-2189. Epub 2011 Nov 23. Erratum in: Clin Cancer Res. 2012 May 1;18(9):2720.

13.

The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination.

Zhao H, Luoto KR, Meng AX, Bristow RG.

Radiother Oncol. 2011 Oct;101(1):59-65. doi: 10.1016/j.radonc.2011.08.013. Epub 2011 Sep 6.

PMID:
21903282
14.

Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.

Luoto KR, Meng AX, Wasylishen AR, Zhao H, Coackley CL, Penn LZ, Bristow RG.

Cancer Res. 2010 Nov 1;70(21):8748-59. doi: 10.1158/0008-5472.CAN-10-0944. Epub 2010 Oct 12.

15.

Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.

Chan N, Pires IM, Bencokova Z, Coackley C, Luoto KR, Bhogal N, Lakshman M, Gottipati P, Oliver FJ, Helleday T, Hammond EM, Bristow RG.

Cancer Res. 2010 Oct 15;70(20):8045-54. doi: 10.1158/0008-5472.CAN-10-2352. Epub 2010 Oct 5.

16.

A functionally distinct member of the DP family of E2F subunits.

Milton A, Luoto K, Ingram L, Munro S, Logan N, Graham AL, Brummelkamp TR, Hijmans EM, Bernards R, La Thangue NB.

Oncogene. 2006 May 25;25(22):3212-8.

PMID:
16418725
17.

Evaluation of exposure to man-made vitreous fibers by nasal lavage.

Paananen H, Holopainen M, Kalliokoski P, Kangas J, Kotilainen M, Pennanen S, Savolainen H, Tossavainen A, Luoto K.

J Occup Environ Hyg. 2004 Feb;1(2):82-7.

PMID:
15204882
18.

Technical knockout, a Drosophila model of mitochondrial deafness.

Toivonen JM, O'Dell KM, Petit N, Irvine SC, Knight GK, Lehtonen M, Longmuir M, Luoto K, Touraille S, Wang Z, Alziari S, Shah ZH, Jacobs HT.

Genetics. 2001 Sep;159(1):241-54.

19.

Production of reactive oxygen species by man-made vitreous fibres in human polymorphonuclear leukocytes.

Ruotsalainen M, Hirvonen MR, Luoto K, Savolainen KM.

Hum Exp Toxicol. 1999 Jun;18(6):354-62.

PMID:
10413242
20.

Dissolution of short and long rockwool and glasswool fibers by macrophages in flowthrough cell culture.

Luoto K, Holopainen M, Kangas J, Kalliokoski P, Savolainen K.

Environ Res. 1998 Jul;78(1):25-37.

PMID:
9630442
21.

Comparison of cytotoxicity of man-made vitreous fibres.

Luoto K, Holopainen M, Sarataho M, Savolainen K.

Ann Occup Hyg. 1997 Jan;41(1):37-50.

PMID:
9072949
22.

Cellular effects of particles--impact of dissolution on toxicity of man-made mineral fibers.

Luoto K, Holopainen M, Perander M, Karppinen K, Savolainen KM.

Cent Eur J Public Health. 1996;4 Suppl:29-32. Review.

PMID:
9167055
23.

The effect of fiber length on the dissolution by macrophages of rockwool and glasswool fibers.

Luoto K, Holopainen M, Kangas J, Kalliokoski P, Savolainen K.

Environ Res. 1995 Jul;70(1):51-61.

PMID:
8603659
24.
26.

PERSONALITY AND PLACEBO EFFECTS UPON TIMING BEHAVIOR.

LUOTO K.

J Abnorm Psychol. 1964 Jan;68:54-61. No abstract available.

PMID:
14105179
27.

Mediation and associative facilitation in neurotic, psychotic, and normal subjects.

LANG PJ, LUOTO K.

J Abnorm Soc Psychol. 1962 Feb;64:113-20. No abstract available.

PMID:
14462054

Supplemental Content

Support Center